Avicanna Inc Total Liabilities

Latest as of June 2026: CA$10.12 Million CAD ≈ $7.32 Million USD

Avicanna Inc total liabilities. Based on the latest financial reports, Avicanna Inc (AVCN) has total liabilities worth CA$10.12 Million CAD (≈ $7.32 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Avicanna Inc (AVCN) asset resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Avicanna Inc (2016–2025)

Total liabilities of Avicanna Inc from 2016 to 2025. This chart illustrates how Avicanna Inc's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Avicanna Inc to see how much of total assets are deployed in long-term investments.

Avicanna Inc Competitors by Total Liabilities

The table below lists competitors of Avicanna Inc ranked by their total liabilities.

Company Country Total Liabilities
Takuni Group Public Company Limited
BK:TAKUNI
Thailand ฿2.09 Billion
O.R.T.
TA:ORTC
Israel ILA7.31 Million
Rigsave S.P.A.
XETRA:H68
USA €51.93 Million
Wetouch Technology Inc. Common Stock
NASDAQ:WETH
USA $4.12 Million
Pivotal Metals Ltd
AU:PVT
Australia AU$279.63K
ECOUP OYJ EO 1
F:62H
Germany €12.21 Million
KDA Group Inc
V:KDA
Canada CA$2.06 Million
ICG Enterprise Trust PLC
LSE:ICGT
UK GBX90.60 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Avicanna Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Avicanna Inc.

Liquidity & Leverage Metrics

Avicanna Inc Total Liabilities Ratios Explained

Avicanna Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.97 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.20 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.42 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Avicanna Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Avicanna Inc (2016–2025)

The table below shows the annual total liabilities of Avicanna Inc from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 CA$9.86 Million
≈ $7.13 Million
-5.00%
2024-12-31 CA$10.38 Million
≈ $7.51 Million
-25.89%
2023-12-31 CA$14.00 Million
≈ $10.13 Million
-1.14%
2022-12-31 CA$14.16 Million
≈ $10.24 Million
-8.01%
2021-12-31 CA$15.39 Million
≈ $11.14 Million
-5.25%
2020-12-31 CA$16.25 Million
≈ $11.75 Million
+6.26%
2019-12-31 CA$15.29 Million
≈ $11.06 Million
+748.74%
2018-12-31 CA$1.80 Million
≈ $1.30 Million
+41.13%
2017-12-31 CA$1.28 Million
≈ $923.33K
+939.73%
2016-12-31 CA$122.76K
≈ $88.80K
--

About Avicanna Inc

TO:AVCN Canada Drug Manufacturers - Specialty & Generic
Market Cap
$10.21 Million
CA$14.11 Million CAD
Market Cap Rank
#26896 Global
#1099 in Canada
Share Price
CA$0.11
Change (1 day)
+5.00%
52-Week Range
CA$0.10 - CA$0.27
All Time High
CA$6.90
About

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios … Read more